Science
DRDO-Developed Technology Behind Critical Drug Approved By DCGI For Radiological And Nuclear Emergencies
Radiation hazard symbol (Pic Via Wikipedia)
The Defence Ministry on Tuesday (12 announced that Prussian blue insoluble formulations, a critical drug developed under the Technology Development Fund for radiological and nuclear emergencies, has been granted approval by the Drugs Controller General of India (DCGI).
The drug has been developed by the industry based on the technology of the Institute of Nuclear Medicine & Allied Sciences (INMAS), Delhi, a laboratory of the Defense Research & Development Organisation (DRDO).
Scott-Edil Pharmacia Ltd, Baddi, Himachal Pradesh and Skanttr Lifescience LLP, Ahmedabad, Gujarat have been granted the licenses for manufacturing and marketing the drug for commercial use.
The drug will be available under the trade name of Pru-DecorpTM and PruDecorp-MG.
The formulations are used for decontamination of Cesium and Thallium and its Active Pharmaceutical Ingredient (API), the Defence Ministry said in a statement.
The drug is a critical medicine listed by the World Health Organization (WHO) for radiological and nuclear emergencies.
Samir V Kamat, secretary department of defence R&D and DRDO chairman, has congratulated the Organisation as well as the industry on this achievement.
He stated that the development of these drug formulations under the TDF project and the approval of DCGI is a successful endeavour of the DRDO for promoting the industry to achieve Prime Minister Narendra Modi’s vision of ‘Aatmanirbhar Bharat’.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest
